E R de Groot - JoVE Visualize

Showing results (11-20 of 32) with videos related to

Pageof 4

Sort By:

European Journal of Immunology|October 1, 1987

Production of hybridoma growth factor by human monocytesL A Aarden, E R De Groot, O L Schaap, et al.

European Journal of Immunology|November 1, 1987

Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systemsR A Van Lier, J H Boot, E R De Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1990

Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutantsJ P Brakenhoff, M Hart, E R De Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1987

Molecular cloning and expression of hybridoma growth factor in Escherichia coliJ P Brakenhoff, E R de Groot, R F Evers, et al.

Immunological Communications|January 1, 1980

Dissociation of DNA/anti-DNA complexes at high pHE R de Groot, M C Lamers, L A Aarden, et al.

Rheumatology (Oxford, England)|June 5, 2003

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritisA H Gerards, S de Lathouder, E R de Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987

Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3R A van Lier, J H Boot, A J Verhoeven, et al.

Scandinavian Journal of Rheumatology|July 2, 2004

Bioassay for detection of methotrexate in serumS de Lathouder, A H Gerards, E R de Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1987

Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodiesG A van Seventer, K C Kuijpers, R A van Lier, et al.

Annals of the Rheumatic Diseases|October 25, 2014

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding regionK A van Schie, M H Hart, E R de Groot, et al.

Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:

Pageof 4

European Journal of Immunology|October 1, 1987

Production of hybridoma growth factor by human monocytesL A Aarden, E R De Groot, O L Schaap, et al.

European Journal of Immunology|November 1, 1987

Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systemsR A Van Lier, J H Boot, E R De Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1990

Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutantsJ P Brakenhoff, M Hart, E R De Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1987

Molecular cloning and expression of hybridoma growth factor in Escherichia coliJ P Brakenhoff, E R de Groot, R F Evers, et al.

Immunological Communications|January 1, 1980

Dissociation of DNA/anti-DNA complexes at high pHE R de Groot, M C Lamers, L A Aarden, et al.

Rheumatology (Oxford, England)|June 5, 2003

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritisA H Gerards, S de Lathouder, E R de Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987

Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3R A van Lier, J H Boot, A J Verhoeven, et al.

Scandinavian Journal of Rheumatology|July 2, 2004

Bioassay for detection of methotrexate in serumS de Lathouder, A H Gerards, E R de Groot, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1987

Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodiesG A van Seventer, K C Kuijpers, R A van Lier, et al.

Annals of the Rheumatic Diseases|October 25, 2014

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding regionK A van Schie, M H Hart, E R de Groot, et al.

Pageof 4